Rules concerning safety and efficacy of drugs, etc. eased

The Korea Food and Drug Administration announced on December 13 that it has revised the rules concerning safety and efficacy of drugs, etc., the salient points of which are as follows:

- The conditions of protocol, types of clinical trials, test methods and assessment criteria for new and generic drugs are internationally harmonized (ICH's CTD), and general pharmacological data will be accep...